Novavax Inc (NVAX)
7.21
-0.56
(-7.21%)
USD |
NASDAQ |
Nov 14, 16:00
7.05
-0.16
(-2.22%)
After-Hours: 17:35
Novavax Gross Profit (Annual): 212.61M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 212.61M |
| December 31, 2022 | 696.31M |
| December 31, 2021 | 197.58M |
| December 31, 2020 | 22.39M |
| December 31, 2019 | |
| December 31, 2018 | |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | 7.384M |
| December 31, 2011 | 7.685M |
| December 31, 2010 | 0.343M |
| Date | Value |
|---|---|
| December 31, 2009 | 0.325M |
| December 31, 2008 | 1.064M |
| December 31, 2007 | 1.292M |
| December 31, 2006 | 1.501M |
| December 31, 2005 | 4.933M |
| December 31, 2004 | 4.77M |
| December 31, 2003 | 9.728M |
| December 31, 2002 | 11.45M |
| December 31, 2001 | 20.01M |
| December 31, 2000 | 3.069M |
| December 31, 1999 | 1.60M |
| December 31, 1998 | 1.00M |
| December 31, 1997 | 0.80M |
| December 31, 1996 | 0.40M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
22.39M
Minimum
2020
696.31M
Maximum
2022
282.22M
Average
205.10M
Median
Gross Profit (Annual) Benchmarks
| Pfizer Inc | 33.54B |
| Moderna Inc | 2.061B |
| Baxter International Inc | 4.975B |
| Inovio Pharmaceuticals Inc | -- |
| AIM ImmunoTech Inc | 0.16M |